SINOPHARM GROUP Company Insiders
| SHTDY Stock | USD 13.31 0.33 2.54% |
SINOPHARM GROUP employs about 113.2 K people. The company is managed by 8 executives with a total tenure of roughly 57 years, averaging almost 7.0 years of service per executive, having 14154.25 employees per reported executive. Break down of SINOPHARM GROUP's management performance can provide insight into the company performance.
| Yong Liu President Vice President Chief Legal Advisor |
| Shuangjun Xu President Non-executive Vice President |
SINOPHARM |
SINOPHARM GROUP Management Team Effectiveness
The company has return on total asset (ROA) of 0.0364 % which means that it generated a profit of $0.0364 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1319 %, meaning that it generated $0.1319 on every $100 dollars invested by stockholders. SINOPHARM GROUP's management efficiency ratios could be used to measure how well SINOPHARM GROUP manages its routine affairs as well as how well it operates its assets and liabilities.SINOPHARM GROUP Workforce Comparison
SINOPHARM GROUP LTD is currently regarded as top stock in number of employees category among its peers. The total workforce of Medical Distribution industry is at this time estimated at about 259,756. SINOPHARM GROUP totals roughly 113,234 in number of employees claiming about 44% of all equities under Medical Distribution industry.
The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.04. SINOPHARM GROUP LTD Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. SINOPHARM GROUP LTD Price Series Summation is a cross summation of SINOPHARM GROUP price series and its benchmark/peer.
SINOPHARM GROUP Notable Stakeholders
A SINOPHARM GROUP stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as SINOPHARM GROUP often face trade-offs trying to please all of them. SINOPHARM GROUP's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting SINOPHARM GROUP's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Yong Liu | Vice President Chief Legal Advisor | Profile | |
| Shuangjun Xu | Non-executive Vice President | Profile | |
| Xiuchang Jiang | CFO, Vice President | Profile | |
| Maisong Cai | Vice President | Profile | |
| Yijian Wu | Non-Executive Director | Profile | |
| Qingming Yu | Executive Director | Profile | |
| Wanyong Lian | Non-Executive Director | Profile | |
| Xiaojuan Li | Chief Officer | Profile |
About SINOPHARM GROUP Management Performance
The success or failure of an entity such as SINOPHARM GROUP LTD often depends on how effective the management is. SINOPHARM GROUP management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of SINOPHARM management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the SINOPHARM management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the Peoples Republic of China. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd. Sinopharm is traded on OTC Exchange in the United States.
Please note, the imprecision that can be found in SINOPHARM GROUP's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of SINOPHARM GROUP LTD. Check SINOPHARM GROUP's Beneish M Score to see the likelihood of SINOPHARM GROUP's management manipulating its earnings.
SINOPHARM GROUP Workforce Analysis
Traditionally, organizations such as SINOPHARM GROUP use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare SINOPHARM GROUP within its industry.SINOPHARM GROUP Manpower Efficiency
Return on SINOPHARM GROUP Manpower
| Revenue Per Employee | 4.6M | |
| Revenue Per Executive | 65.1B | |
| Net Income Per Employee | 68.5K | |
| Net Income Per Executive | 969.8M | |
| Working Capital Per Employee | 284.9K | |
| Working Capital Per Executive | 4B |
Additional Tools for SINOPHARM Pink Sheet Analysis
When running SINOPHARM GROUP's price analysis, check to measure SINOPHARM GROUP's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SINOPHARM GROUP is operating at the current time. Most of SINOPHARM GROUP's value examination focuses on studying past and present price action to predict the probability of SINOPHARM GROUP's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SINOPHARM GROUP's price. Additionally, you may evaluate how the addition of SINOPHARM GROUP to your portfolios can decrease your overall portfolio volatility.